Tirzepatide powder (CAS 2023788-19-2) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for type 2 diabetes research. This white crystalline powder demonstrates superior efficacy in glucose control and weight management compared to selective GLP-1 receptor agonists.
The compound works through multiple mechanisms: slowing gastric emptying, reducing hepatic glucose production, and enhancing insulin secretion in a glucose-dependent manner. Research indicates tirzepatide powder may help regulate blood glucose levels, reduce hemoglobin A1c, and support weight management through appetite regulation.
For researchers seeking tirzepatide powder where to buy, we offer pharmaceutical grade material with comprehensive analytical documentation. Our production follows strict GMP standards to ensure batch-to-batch consistency and purity.
Key research applications include metabolic disorder studies, diabetes mechanisms investigation, and obesity-related research. The dual receptor activity makes this compound particularly valuable for comparative studies against single-receptor agonists.